Automate Your Wheel Strategy on HSIC
With Tiblio's Option Bot, you can configure your own wheel strategy including HSIC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HSIC
- Rev/Share 102.3542
- Book/Share 38.1253
- PB 2.7178
- Debt/Equity 0.974
- CurrentRatio 1.384
- ROIC 0.0581
- MktCap 8846609600.0
- FreeCF/Share 4.185
- PFCF 17.0784
- PE 22.1033
- Debt/Assets 0.3076
- DivYield 0
- ROE 0.1187
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HSIC | Wells Fargo | -- | Equal Weight | -- | $80 | Feb. 14, 2025 |
| Upgrade | HSIC | BofA Securities | Underperform | Buy | $69 | $84 | Jan. 6, 2025 |
| Initiation | HSIC | Mizuho | -- | Neutral | -- | $75 | Dec. 4, 2024 |
News
Here's Why Henry Schein (HSIC) is a Strong Value Stock
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Published: June 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Read More
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.
Read More
Henry Schein to Participate in Upcoming Investor Conferences in May
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 14, 2025, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time). Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 29, 2025, at 12:40 p.m. Eastern time.
Read More
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Henry Schein (HSIC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Negative
HSIC ends the first quarter of 2025 on a mixed note.
Read More
Henry Schein: An Industry Leader That Offers Some Upside From Here
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Positive
Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisitions, with significant improvements in net income and operating cash flow.
Read More
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
Read More
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
Published: February 25, 2025 by: Business Wire
Sentiment: Neutral
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial results and guidance being provided today are consistent with the preliminary financial results and guidance provided on January 29th. “Our fourth quarter financial results reflect relatively stable dental and medical.
Read More
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
Read More
About Henry Schein, Inc. (HSIC)
- IPO Date 1995-11-03
- Website https://www.henryschein.com
- Industry Medical - Distribution
- CEO Stanley M. Bergman CPA
- Employees 25000